2018
DOI: 10.1097/md.0000000000010157
|View full text |Cite
|
Sign up to set email alerts
|

Risks of female genital tract related cancers (gynecological cancers) or breast cancer in women with and without chronic kidney disease

Abstract: Supplemental Digital Content is available in the text

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 71 publications
0
4
0
Order By: Relevance
“…If a three-fold increase in liver enzymes of patients was detected, paclitaxel (60 mg/m 2 ) was used. The cisplatin dose was decreased to half dosage if the estimated glomerular filtration rate (eGFR) was decreased to 45-60 ml/min, which was calculated using the Cockcroft-Gault formula [122][123][124].…”
Section: Treatmentmentioning
confidence: 99%
“…If a three-fold increase in liver enzymes of patients was detected, paclitaxel (60 mg/m 2 ) was used. The cisplatin dose was decreased to half dosage if the estimated glomerular filtration rate (eGFR) was decreased to 45-60 ml/min, which was calculated using the Cockcroft-Gault formula [122][123][124].…”
Section: Treatmentmentioning
confidence: 99%
“…RCC progression is usually accompanied with uncontrollable proliferation, distant metastasis and recurrence. 4 7 However, the exact molecular mechanism of RCC is still unclear and needs to be further investigated.…”
Section: Introductionmentioning
confidence: 99%
“…The modification of dose scheduling and intensity is one of the targeted strategies for improving the prognosis of advanced EOC, FTC, and PPSC [39,40,43,50]. Our study tried to evaluate the outcome of patients with FIGO stage IIIC–IV EOC, FTC, and PPSC treated with dose-dense weekly paclitaxel and low-dose triweekly cisplatin regimen.…”
Section: Discussionmentioning
confidence: 99%
“…Paclitaxel was reduced by 20% and cisplatin was withheld if febrile neutropenia or grade 3/4 neutropenia was noted. The estimated glomerular filtration rate (eGFR) was calculated according to the Cockcroft-Gault formula [49][50][51], and cisplatin was reduced by 50% if the eGFR decreased to 45-60 ml/min or was held for one cycle if the eGFR was less than 45 ml/min.…”
Section: Treatmentmentioning
confidence: 99%